tiprankstipranks
Kissei Pharmaceutical Co (JP:4547)
:4547
Japanese Market

Kissei Pharmaceutical Co (4547) Income Statement

Compare
0 Followers

Kissei Pharmaceutical Co Income Statement

Last quarter (Q1 2024), Kissei Pharmaceutical Co's total revenue was ¥21.16B, an increase of 9.58% from the same quarter last year. In Q1, Kissei Pharmaceutical Co's net income was ¥4.11B. See Kissei Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 75.58B¥ 67.49B¥ 65.38B¥ 69.04B¥ 63.24B
Gross Profit
¥ 37.34B¥ 32.38B¥ 31.24B¥ 32.72B¥ 34.91B
Operating Expenses
¥ 33.32B¥ 33.50B¥ 32.64B¥ 31.22B¥ 33.05B
Depreciation and Amortization
¥ 4.25B¥ 4.11B¥ 3.73B¥ 3.15B¥ 2.56B
EBITDA
¥ 18.72B¥ 17.81B¥ 20.26B¥ 10.65B¥ 7.21B
Operating Income
¥ 4.02B¥ -1.13B¥ -1.40B¥ 1.50B¥ 1.86B
Other Income/Expenses
¥ 10.43B¥ 14.81B¥ 17.91B¥ 5.97B¥ 2.77B
Pretax Income
¥ 14.45B¥ 13.68B¥ 16.51B¥ 7.48B¥ 4.63B
Net Income
¥ 11.16B¥ 10.53B¥ 12.92B¥ 5.29B¥ 2.82B
Per Share Metrics
Basic EPS
¥ 246.58¥ 228.30¥ 280.19¥ 113.25¥ 60.30
Diluted EPS
¥ 246.58¥ 228.30¥ 280.19¥ 113.25¥ 60.30
Weighted Average Shares Outstanding
45.26M 46.12M 46.12M 46.67M 46.72M
Weighted Average Shares Outstanding (Diluted)
45.26M 46.12M 46.12M 46.67M 46.72M
Currency in JPY

Kissei Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis